Gritstone bio (GRTS) Stock Analysis

What Gritstone bio does

Gritstone bio, Inc. is a clinical-stage biotechnology company focused on pioneering immunotherapies to address various types of cancer and infectious diseases. Its primary product candidate, GRANITE, is a neoantigen-based immunotherapy designed to treat a range of solid tumors, specifically including metastatic non-small cell lung cancer, gastroesophageal, bladder, and microsatellite stable colorectal cancers. Gritstone bio is also advancing SLATE, an off-the-shelf immunotherapy candidate aimed at common solid tumors such as metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and those with shared neoantigens. Furthermore, the company is developing CORAL, a SARS-CoV-2 vaccine platform intended to provide broader and more robust immunity against variants by delivering both spike and additional SARS-CoV-2 T cell epitopes. It is also working on a therapeutic vaccine candidate focused on treating and potentially curing human immunodeficiency virus (HIV) infection. Gritstone bio maintains key partnerships, including a strategic collaboration with bluebird bio, Inc., a collaboration agreement with Gilead Sciences, Inc., and a license agreement with Genevant Sciences GmbH. Founded in 2015 and headquartered in Emeryville, California, the company operated as Gritstone Oncology, Inc. until its rebranding to Gritstone bio, Inc. in May 2021.

Key metrics

ETFs linked to GRTS

Broad-market and Healthcare sector ETFs an investor holding Gritstone bio is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how GRTS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Gritstone bio?

Gritstone bio trades under the ticker GRTS on NASDAQ.

Which exchange is GRTS listed on?

GRTS is listed on NASDAQ.

What sector does Gritstone bio operate in?

Gritstone bio is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze GRTS in a portfolio?

PortView shows GRTS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.